drugset / Trial / NCT07292038
Safety and Pharmacokinetics of NM6603 in Chinese Patients With Advanced Solid Tumors
NaSequentialOpen-labelTreatment
Summary
This study is to assess the MTD and PK of NM6603 in adult patients with advanced solid tumors.
Timeline
- Start
- 2025-12-18
- Primary completion
- 2026-11
- Completion
- 2026-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NM6603 | Small molecule | — | Oral |
Indications
No indication recorded.